Menopause

Daré Bioscience Announces Positive Phase 1 Results for DARE-HRT1 Supporting its Potential as the First Monthly Therapy for both the Vasomotor and Vaginal Symptoms of Menopause

Daré Bioscience has announced positive topline results from its Phase 1 clinical trial of DARE-HRT1. DARE-HRT1 is a novel IVR designed to deliver bio-identical 17β-estradiol and bio-identical progesterone continuously over a 28-day period as part of a hormone therapy (HT) regimen to treat the vasomotor symptoms (VMS) and genitourinary syndrome associated with menopause. The topline data from the study support DARE-HRT1’s potential to…

Kindra Raises a $4.5 Million Seed Round To Further Grow its Women’s Wellness Brand Focused On Menopause

Kindra, a modern wellness brand for menopause essentials, announced today that it closed a $4.5 million seed funding round. The new capital will be used to drive the continued growth and expansion of Kindra. The round is led by the Female Founders Fund. Primetime Partners, Anne and Susan Wojcicki, Katie Couric Media, The Community Fund, and H Ventures are also investors in this round. Helmed…

Psychedelic Biotech Eastra Health Launches with Plans to Address Menopause and PMS

Today saw the launch of Eastra Health, the world’s first female-focused biotech company dedicated to developing psychedelic-derived medicines specifically for women. Eastra Health will offer new solutions for under-addressed health conditions like menstrual pain or menopause through an innovative approach to drug discovery and a deep, holistic understanding of women’s health, biology, and specific needs. “For years, women have been overlooked by…

#menopossibilities: Women in Sport Partners with Getty Images to Launch a Curation of Images Challenging the Way Women Going Through Menopause Are Portrayed

Women in Sport has teamed up with Getty Images to launch a curation of ground-breaking images and short films that challenge the way women going through the menopause are portrayed.   They showcase women who have experienced menopause, illustrating the joy of exercise and how it changed their lives building community, friendship, adventure, fun and camaraderie. Women in midlife feel largely ignored, invisible…

Bossa Bars Launches a New Menopause Energy Bar and Community to Empower Women in Their Midlife Prime

Bossa Bars, plant-based bars created with menopausal female’s health in mind, has just launched with a bold new energy bar (and community) into the explosively growing $600 billion-dollar Menopausal market. The female-founded, mission-based company, is focused on empowering women in perimenopause through post-menopause, to help support daily nutritional needs and provide a community of sister-hood with real and positive information about this…

Menopause: TherapeuticsMD Launches a Bold, New Campaign Promoting Imvexxy, Its Estrogen Softgel Insert That Treats Vaginal Dryness

“Your vagina is queen. Imvexxy is her ally. Long may she reign.” Imvexxy by TherapeuticsMD is the only bio-identical estrogen softgel insert available today. It was first approved in May 2018, when the drug launched with a small campaign. Last week, however, Imvexxy, made a comeback with a bold, new campaign: “Reign”. The new video ad is period-drama (think Bridgerton) inspired and…

Unilever Ventures-Backed Womaness Launches a Collection of New Menopause Products

Unilever Ventures-backed Womaness launches a collection of modern, effective menopause products created by women, for women that offer solutions from head to toe and everything in between. The Womaness line includes 13 products, all under $40, across the skin and body care, feminine care/sexual health, and supplement categories and is available at womaness.com as well as at a nationwide retailer. Womaness was born…

Bonafide Names Dr. Alyssa Dweck as Chief Medical Officer as the Company Leads the Movement to Provide Hormone-Free Menopause Treatment

Bonafide, the company pioneering mainstream medical use of drug-free, naturally derived health solutions for menopause, announces today that Dr. Alyssa Dweck will join its team as its Chief Medical Officer. Bonafide’s products are already trusted by over 9,000 unpaid health care professionals, primarily OBGYNs, and more than 70,000 women.  The addition of Dr. Dweck to Bonafide’s leadership team is in alignment with…